Neuroone Medical Technologies (NMTC) Cash from Financing Activities (2010 - 2026)
Neuroone Medical Technologies' (NMTC) quarterly Cash from Financing Activities came in at $609622.0 in Q1 2026, up 148.61% YoY from $245216.0 in Q1 2025, and up 312.4% on a QoQ basis from $147823.0 in Q4 2025.
Neuroone Medical Technologies (NMTC) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Neuroone Medical Technologies (NMTC) has 16 years of Cash from Financing Activities data on file, last reported at $609622.0 in Q1 2026.
- Quarterly Cash from Financing Activities rose 148.61% year-over-year to $609622.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.1 million (up 135.68% YoY) and the FY2025 annual result came in at $8.0 million, up 10.45% from the prior year.
- Cash from Financing Activities improved to $609622.0 in Q1 2026, from $147823.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $8.2 million in Q2 2025 to a low of -$509325.0 in Q4 2024.
- A 5-year average of $1.6 million and a median of $661961.0 in 2023 frame the typical range for Cash from Financing Activities.
- Annual changes were most pronounced in 2023 — Cash from Financing Activities jumped 205677.95% — and 2024, when it tumbled 142.27%.
- Tracing NMTC's Cash from Financing Activities over 5 years: stood at -$15713.0 in 2022, then jumped by 7768.9% to $1.2 million in 2023, then tumbled by 142.27% to -$509325.0 in 2024, then surged by 129.02% to $147823.0 in 2025, then surged by 312.4% to $609622.0 in 2026.
- The last three Cash from Financing Activities figures came in at $609622.0 (Q1 2026), $147823.0 (Q4 2025), and $66978.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Neuroone Medical Technologies | 19.38 Mn | 17.33 Mn | 1.18 Mn | 345,033.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 345,033.00 |
| Jun 30, 2026 | 345,033.00 |
| Mar 31, 2026 | 609,622.00 |
| Mar 31, 2026 | 609,622.00 |
| Dec 31, 2025 | 147,823.00 |
| Dec 31, 2025 | 147,823.00 |
| Sep 30, 2025 | 66,978.00 |
| Sep 30, 2025 | 66,978.00 |
| Jun 30, 2025 | 8.23 Mn |
| Jun 30, 2025 | 8.23 Mn |
| Mar 31, 2025 | 245,216.00 |
| Mar 31, 2025 | 245,216.00 |
| Dec 31, 2024 | -509,325.00 |
| Dec 31, 2024 | -509,325.00 |
| Sep 30, 2024 | 2.54 Mn |
| Sep 30, 2024 | 2.54 Mn |
| Jun 30, 2024 | 1.56 Mn |
| Jun 30, 2024 | 1.56 Mn |
| Mar 31, 2024 | 1.96 Mn |
| Mar 31, 2024 | 1.96 Mn |